A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism
- Resource Type
- Short Communication
- Source
- In
Biochemical and Biophysical Research Communications 1 October 2023 675:113-121 - Subject
- Language
- ISSN
- 0006-291X